As a result, patients may experience a range of gastrointestinal symptoms, including nausea, vomiting, and, notably, diarrhea
Cardiovascular Benefits : In people with high cardiovascular risk, Liraglutide has demonstrated the ability to reduce the risk of death from cardiovascular causes Enhanced Glycaemic Control: Liraglutide significantly improves blood glucose regulation by increasing insulin secretion, reducing glucagon release, and improving insulin sensitivity, making Liraglutide hugely beneficial for patients with type 2 diabetes or those with prediabetes
The clinical results justify the hype
The STEP UP and STEP UP T2D clinical trials are the first to investigate whether increasing the dose of semaglutide from the currently approved dose of 24 mg to 72 mg is safe and leads to additional weight reduction
Our L-Carnitine Tartrate helps energy production at the cellular level, enhancing your daily activities without the jitters